NB News
The latest news and developments in the eye health and sight loss sector.
-
Information resource on albinism launched
EnglishA free information resource on albinism is now available for eye health and sight loss professionals.
-
Observing Ramadan? Don't stop eye drop medication if you have glaucoma
EnglishMuslims fasting during the month of Ramadan, which starts this week, are being advised not to stop taking eye drop medication if they have glaucoma.
-
Updates to RNIB’s Sight Loss Data Tool
EnglishRNIB’s Sight Loss Data Tool has some significant new data, including figures for new registrations and ophthalmology appointments in 2017.
-
Breakthrough in treatment for AMD as patients regain sight
EnglishTwo patients with advanced wet age-related macular degeneration have regained enough sight to read after undergoing treatment with stem cells.
-
Research and medical roundup
EnglishNB rounds up some recent news and developments in the eye health research and medical world.
-
Campaign to reinstate low vision assessments
UndefinedRNIB, Local Sight Loss Societies and eye health professionals in the East Midlands are challenging a decision to remove low vision assessments.
-
New clinical guidance for AMD published
EnglishThe National Institute of Health and Care Excellence (NICE) have published new clinical guidance to improve care for people with suspected late stage age-related macular degeneration (AMD).
-
Moorfields Eye Centre at St George’s Hospital closed for refurbishment
UndefinedMoorfields Eye Centre at Duke Elder ward, St George’s Hospital, is closed for improvement works from January 2018.
-
Report published highlighting the growing issue of eye health in London
UndefinedThe report indicates that eye health is a growing issue in London and estimates the number of Londoners living with eye conditions is set to increase in the future.
-
Scientists given £1m to create a retinal model from stem cells
UndefinedA Newcastle University research team have been awarded £1m to advance understanding of retinal disease and help develop new treatments.
